Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 7/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ACE | P12821 | 2/20 | 0.35 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.34 |
| ▸ | ANPEP | P15144 | 1/20 | 0.34 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.34 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.34 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.31 |
| ▸ | MME | P08473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL218863 | 1.00 | FOLH1 (0.39) | FOLH1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL1775718 | 0.84 | — | — | |
| SCHEMBL57052 | 0.84 | — | — | |
| SCHEMBL1830619 | 0.84 | — | — | |
| SCHEMBL3263169 | 0.82 | — | — | |
| SCHEMBL9486335 | 0.80 | FOLH1 (0.38) | FOLH1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL31510814 | 0.80 | ACE (0.42) | FOLH1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL9633039 | 0.80 | FOLH1 (0.38) | FOLH1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL4543595 | 0.80 | KDM4E (0.47) | FOLH1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL5372700 | 0.80 | KDM4E (0.47) | FOLH1KDM4EMAPTTHRBALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006084322-A1 | TREATMENT METHOD FOR MODIFYING TISSUE PASSIVE ELECTRICAL CONDUCTANCE | MCLACHLAN CRAIG STEVEN (AU) | 2006-08-17 | — | — | WO | claimed |
| EP-1109543-A4 | NITROSATED AND NITROSYLATED PHOSPHODIESTERASE INHIBITORS, COMPOSITIONS AND METHODS OF USE | NITROMED INC (US) | 2006-03-08 | — | — | EP | claimed |
| EP-1154771-A4 | NITROSATED AND NITROSYLATED PROTON PUMP INHIBITORS, COMPOSITIONS AND METHODS OF USE | NITROMED INC (US) | 2005-04-20 | — | — | EP | claimed |
| JP-2002537336-A | — | — | 2002-11-05 | — | — | JP | claimed |
| EP-1154771-A1 | NITROSATED AND NITROSYLATED PROTON PUMP INHIBITORS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2001-11-21 | — | — | EP | claimed |
| EP-1109543-A1 | NITROSATED AND NITROSYLATED PHOSPHODIESTERASE INHIBITORS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2001-06-27 | — | — | EP | claimed |
| WO-2000067754-A1 | NITROSATED AND NITROSYLATED POTASSIUM CHANNEL ACTIVATORS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2000-11-16 | — | — | WO | claimed |
| WO-2000051978-A1 | NITROSATED AND NITROSYLATED PROSTAGLANDINS, COMPOSITIONS AND METODS OF USE | NITROMED, INC. (US) | 2000-09-08 | — | — | WO | claimed |
| WO-2000050037-A1 | NITROSATED AND NITROSYLATED PROTON PUMP INHIBITORS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2000-08-31 | — | — | WO | claimed |
| WO-2000012076-A9 | NITROSATED AND NITROSYLATED PHOSPHODIESTERASE INHIBITORS, COMPOSITIONS AND METHODS OF USE | NITROMED INC (US) | 2000-08-17 | — | — | WO | claimed |
| WO-2000012076-A1 | NITROSATED AND NITROSYLATED PHOSPHODIESTERASE INHIBITORS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2000-03-09 | — | — | WO | claimed |
| WO-1997018000-A1 | S-NITROSO-HEMOGLOBIN AND THERAPEUTIC USES THEREOF | BRIGHAM AND WOMEN'S HOSPITAL (US) | 1997-05-22 | — | — | WO | claimed |
| US-5626738-A | Methods for the separation and detection of nitrosothiols | AMERICAN HEALTH FOUNDATION (US) | 1997-05-06 | — | — | US | claimed |
| WO-2006084322-A1 | TREATMENT METHOD FOR MODIFYING TISSUE PASSIVE ELECTRICAL CONDUCTANCE | MCLACHLAN CRAIG STEVEN (AU) | 2006-08-17 | — | — | WO | disclosed |
| WO-2006076225-A2 | METHODS AND SYSTEMS FOR IDENTIFYING AND MONITORING S-NITROSOTHIOLS IN BIOLOGICAL SAMPLES | WHALEN ERIN J (US) | 2006-07-20 | — | — | WO | disclosed |
| EP-1015490-A1 | NO-MODIFIED HEMOGLOBINS AND USES THEREFOR | DUKE UNIVERSITY MEDICAL CENTER (US) | 2000-07-05 | — | — | EP | disclosed |
| EP-0582631-A1 | S-NITROSOTHIOLS AS SMOOTH MUSCLE RELAXANTS AND THERAPEUTIC USES THEREOF | BRIGHAM AND WOMEN'S HOSPITAL (US) | 1994-02-16 | — | — | EP | disclosed |
| WO-1993012068-A1 | S-NITROSOTHIOLS AS SMOOTH MUSCLE RELAXANTS AND THERAPEUTIC USES THEREOF | BRIGHAM AND WOMEN'S HOSPITAL (US) | 1993-06-24 | — | — | WO | disclosed |
| WO-1992018002-A1 | NITROSATION OF HOMOCYSTEINE AS A METHOD FOR TREATING HOMOCYSTEINEMIA | BRIGHAM AND WOMEN'S HOSPITAL (US) | 1992-10-29 | — | — | WO | disclosed |
| WO-1992017445-A2 | S-NITROSOTHIOLS AS SMOOTH MUSCLE RELAXANTS AND THERAPEUTIC USES THEREOF | BRIGHAM AND WOMEN'S HOSPITAL (US) | 1992-10-15 | — | — | WO | disclosed |